Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Paul Mayhew-Archer visited the Oxford Parkinson's Disease Centre (OPDC) to find out more about our cutting edge research.

Parkinson's

After being diagnosed with Parkinson's five years ago, comedy writer Paul Mayhew-Archer decided to investigate what research was being done into pioneering new treatments for the disease. In the last few months, Paul has visited the OPDC where researchers are trying to determine the molecular pathways of Parkinson's disease.

The result of his visits: 'Parkinson's: The Funny Side' was shown on BBC One on Monday 7th March and is available to view on iPlayer until 6th April 2016. 

Paul was joined by DPAG's  Professor Richard Wade-Martins, Principal Investigator of the OPDC, who talked about our research using stem cell technology to grow and study dopamine neurons from Parkinson's patients' skin cells to identify potential targets for treatments. The BBC One Saturday Breakfast News clip can be viewed here.

Similar stories

Physiology drawings enhance our understanding of the 'Amazing Body'

Outreach

Visiting academic Dr Lizzie Burns received an outreach grant from The Physiological Society to create a novel set of engaging drawings for adult colouring-in to learn about our remarkable human body. Dr Burns has collaborated with members of The Society, including DPAG's Heidi de Wet, Peter Robbins, Keith Dorrington and Andrew King, to illustrate a wide range of physiological topics.

New laboratory space for OPDC Researchers

OPDC News

A major building in the centre of Oxford has been constructed to create a new research centre bringing together cellular neuroscience and physical sciences.

Dopamine neurons need a 'REST' in Parkinson’s Disease

OPDC News

A study led by University of Oxford researchers, Dr Brent Ryan and Dr Nora Bengoa-Vergniory has shown that the key protein RE1 Silencing Transcription Factor (REST) regulates the health of those neurons critically affected in Parkinson’s Disease.

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease

OPDC News

A study led by the Oxford Parkinson’s Disease Centre’s (OPDC) Dr Nora Bengoa-Vergniory has shown that a novel assay termed the tau-proximity ligation assay is able to recognise Alzheimer’s disease before current detection methods.

Just over half of British Indians would take COVID vaccine

EDI News Outreach Postdoctoral Publication Research Riley Group News

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.